Fig. 7From: Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancerH19 oncogenic activity is in part through negative regulation of miR-342-3p in vivo (a) Representation picture of tumor formation of xonograft in nude mice in lv-control, lv-shRNA-H19, lv-miR-342-3p inhibitor and lv-shRNA-H19+ miR-342-3p inhibitor group, respectively (each group n = 4). b Summery of tumor volume of mice which were measured in every week in lv-control, lv-shRNA-H19, lv-miR-342-3p inhibitor and lv-shRNA-H19+ miR-342-3p inhibitor group, respectively. c Representation of FOXM1 expression in xenografts tumor using IHC method in lv-control, lv-shRNA-H19, lv-miR-342-3p inhibitor and lv-shRNA-H19+ miR-342-3p inhbitor group, respectively. d Statistical analyses of IHC results in xenograft tumor in lv-control, lv-shRNA-H19, lv-miR-342-3p inhbitor and lv-shRNA-H19+ miR-342-3p inhbitor group, respectivelyBack to article page